Concepedia

Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial

Concepción F. Estívariz, Abhijeet Anand, Howard E. Gary, Mahmudur Rahman, Jannatul Islam, Tajul Islam A Bari, Steven G.F. Wassilak, Susan Y. Chu, William C. Weldon, Mark A. Pallansch,

The Lancet Infectious Diseases · 2015 · 27 citations · 15 references

DOIFull text

Open access

Concepts

References

15

WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age - Methods and development

Mercedes de Onís, Adelheid W. Onyango, Elaine Borghi et al. · (2006) · 2006 · 3.5K citations

, , +14

Progress Toward Polio Eradication — Worldwide, 2015–2016

Michelle Morales, Rudolf H. Tangermann, Steven G.F. Wassilak · MMWR Morbidity and Mortality Weekly Report · 2016 · 185 citations · Full text

, , +11

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

Roland W. Sutter, T. Jacob John, Hemant Jain et al. · The Lancet · 2010 · 143 citations

, , +14

Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine: A Prospective Evaluation in Brazil and the Gambia

The Journal of Infectious Diseases · 1995 · 113 citations

, , +14

Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age

Khalequ Zaman, David A. Sack, Mohammad Yunus et al. · Vaccine · 2009 · 109 citations

, , +17